These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 22950376

  • 1. Paroxetine use during pregnancy and perinatal outcomes including types of cardiac malformations in Quebec and France: a short communication.
    Bérard A, Sheehy O, Damase-Michel C, Crespin S.
    Curr Drug Saf; 2012 Jul; 7(3):207-10. PubMed ID: 22950376
    [Abstract] [Full Text] [Related]

  • 2. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.
    Bérard A, Ramos E, Rey E, Blais L, St-André M, Oraichi D.
    Birth Defects Res B Dev Reprod Toxicol; 2007 Feb; 80(1):18-27. PubMed ID: 17187388
    [Abstract] [Full Text] [Related]

  • 3. Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.
    Bar-Oz B, Einarson T, Einarson A, Boskovic R, O'Brien L, Malm H, Bérard A, Koren G.
    Clin Ther; 2007 May; 29(5):918-926. PubMed ID: 17697910
    [Abstract] [Full Text] [Related]

  • 4. SSRI antidepressants and birth defects.
    Prescrire Int; 2006 Dec; 15(86):222-3. PubMed ID: 17167929
    [Abstract] [Full Text] [Related]

  • 5. Paroxetine may increase risk for congenital malformations.
    Cuzzell JZ.
    Dermatol Nurs; 2006 Feb; 18(1):68. PubMed ID: 16617525
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy.
    Einarson A, Pistelli A, DeSantis M, Malm H, Paulus WD, Panchaud A, Kennedy D, Einarson TR, Koren G.
    Am J Psychiatry; 2008 Jun; 165(6):749-52. PubMed ID: 18381907
    [Abstract] [Full Text] [Related]

  • 7. The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis.
    Bérard A, Iessa N, Chaabane S, Muanda FT, Boukhris T, Zhao JP.
    Br J Clin Pharmacol; 2016 Apr; 81(4):589-604. PubMed ID: 26613360
    [Abstract] [Full Text] [Related]

  • 8. Paroxetine in the first trimester and the prevalence of congenital malformations.
    Cole JA, Ephross SA, Cosmatos IS, Walker AM.
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1075-85. PubMed ID: 17729379
    [Abstract] [Full Text] [Related]

  • 9. Counseling pregnant women treated with paroxetine. Concern about cardiac malformations.
    Einarson A, Koren G.
    Can Fam Physician; 2006 May; 52(5):593-4. PubMed ID: 16739830
    [Abstract] [Full Text] [Related]

  • 10. Should paroxetine be used to treat depression during pregnancy?
    Mintzes B, Jureidini J.
    Am J Psychiatry; 2008 Nov; 165(11):1487; author reply 1487-8. PubMed ID: 18981077
    [No Abstract] [Full Text] [Related]

  • 11. Paroxetine use in pregnancy and increased risk of heart defects: Evaluating the evidence.
    Einarson A.
    Can Fam Physician; 2010 Aug; 56(8):767-8. PubMed ID: 20705881
    [Abstract] [Full Text] [Related]

  • 12. Does paroxetine cause cardiac malformations?
    O'Brien L, Einarson TR, Sarkar M, Einarson A, Koren G.
    J Obstet Gynaecol Can; 2008 Aug; 30(8):696-701. PubMed ID: 18786292
    [Abstract] [Full Text] [Related]

  • 13. First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies.
    Wurst KE, Poole C, Ephross SA, Olshan AF.
    Birth Defects Res A Clin Mol Teratol; 2010 Mar; 88(3):159-70. PubMed ID: 19739149
    [Abstract] [Full Text] [Related]

  • 14. [Drug in pregnancy: studies in the French database EFEMERIS].
    Damase-Michel C, Lacroix I, Hurault-Delarue C, Beau AB, Montastruc JL, les partenaires d’EFEMERIS.
    Therapie; 2014 Mar; 69(1):91-100. PubMed ID: 24698193
    [Abstract] [Full Text] [Related]

  • 15. First-trimester exposure to bupropion and risk of cardiac malformations.
    Louik C, Kerr S, Mitchell AA.
    Pharmacoepidemiol Drug Saf; 2014 Oct; 23(10):1066-75. PubMed ID: 24920293
    [Abstract] [Full Text] [Related]

  • 16. Annual trends in use of periconceptional folic acid and birth prevalence of major congenital malformations.
    Richard-Tremblay AA, Sheehy O, Bérard A.
    Curr Drug Saf; 2013 Jul; 8(3):153-61. PubMed ID: 23845112
    [Abstract] [Full Text] [Related]

  • 17. Systematic meta-analysis of individual selective serotonin reuptake inhibitor medications and congenital malformations.
    Myles N, Newall H, Ward H, Large M.
    Aust N Z J Psychiatry; 2013 Nov; 47(11):1002-12. PubMed ID: 23761574
    [Abstract] [Full Text] [Related]

  • 18. GSK is sued in US over alleged link of paroxetine to birth defects.
    Tanne JH.
    BMJ; 2009 Oct 12; 339():b3967. PubMed ID: 19822609
    [No Abstract] [Full Text] [Related]

  • 19. The effect of ascertainment bias in evaluating gestational antidepressant exposure.
    Koren G.
    J Popul Ther Clin Pharmacol; 2011 Oct 12; 18():e174-5. PubMed ID: 21471609
    [Abstract] [Full Text] [Related]

  • 20. Bupropion (amfebutamone): caution during pregnancy.
    Prescrire Int; 2005 Dec 12; 14(80):225. PubMed ID: 16400747
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.